NCT00083473View on ClinicalTrials.gov

A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia

PHASE2TerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

April 30, 2005

Conditions
Leukemia, Lymphocytic, ChronicLymphoma, Small Lymphocytic
Interventions
DRUG

Pivanex

Trial Locations (1)

10021

Center for Lymphoma and Myeloma; Weill Medical College of Cornell University, New York

Sponsors
All Listed Sponsors
lead

Titan Pharmaceuticals

INDUSTRY

NCT00083473 - A Pilot Study of Pivanex in Patients With Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter